Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Valrubicin

Valrubicin

pharmaceutical raw materials
Valrubicin structure

Valrubicin 

structure
  • CAS No:

    56124-62-0

  • Formula:

    C34H36F3NO13

  • Chemical Name:

    Valrubicin

  • Synonyms:

    Pentanoic acid,2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester;Pentanoic acid,2-[1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester,(2S-cis)-;Pentanoic acid,2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethyl ester;AD 32;Antibiotic AD 32;N-Trifluoroacetyladriamycin 14-valerate;NSC 246131;N-Trifluoroacetyldoxorubicin 14-valerate;Valrubicin;Valstar;Trifluoroacetyladriamycin 14-valerate;136816-53-0

  • Categories:

    Active Pharmaceutical Ingredients  >  Antineoplastic Agents

Description

Valrubicin is a chemotherapy agent, inhibits TPA- and PDBu-induced PKC activation with IC50s of 0.85 and 1.25 μM, respectively, and has antitumor and antiinflammatory activity.


Solid

Valrubicin Basic Attributes

723.64

723.64

1312995-182-4

246131

2941906000

Characteristics

215

4

1.5±0.1 g/cm3

116-117 °C

135-136 C

478.6±34.3 °C

1.619

H2O: insoluble

dnd-hmn:lym 3 mg/L CJBIAE 58,720,80

Safety Information

2811

36/37/38

26-37/39

Xi

P201, P202, P261, P264, P270, P271, P280, P281, P301+P310, P302+P352, P304+P312, P304+P340, P308+P313, P312, P321, P322, P330, P363, P405, P501

H301

Drug Information

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)|Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

AD 32

Valrubicin Use and Manufacturing

Chemotherapy drug used to treat cancer of the bladder.

Computed Properties

Molecular Weight:723.6
XLogP3:4
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:16
Rotatable Bond Count:11
Exact Mass:723.21387469
Monoisotopic Mass:723.21387469
Topological Polar Surface Area:215
Heavy Atom Count:51
Complexity:1350
Defined Atom Stereocenter Count:2
Undefined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Valrubicin

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.